Richard Vincent | CFO |
Dr. Jim Breitmeyer | President and CEO |
Dr. Frank Hsu | Chief Medical Officer |
Hartaj Singh | Oppenheimer |
Matt Kaplan | Ladenburg |
Carl Byrnes | Northland Securities |
Greetings, ladies and gentlemen, and welcome to the Oncternal Therapeutics Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host Richard Vincent, Chief Financial Officer.